Mezzion Pharma
Feb 07, 2017
FDA approves; Sun Pharma Recalls; Mezzion filed; Sanofi’s antibody to treat
FDA approves Bristol-Myers Squibb’s Opdivo injection to treat mUC Bristol-Myers Squibb’s Opdivo injection (nivolumab) has been approved by U.S. FDA for intravenous use in previously treated, locally advanced or metastatic urothelial carcinoma (mUC), a type of bladder cancer. This indication is approved based on tumo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
